Jeffrey W. Dunn is the CEO of SI-BONE, Inc., where he has been leading the company since it was started in 2008. With a Bachelor's degree in Engineering and an MBA, he brings a solid educational background to his role....

Jeffrey W. Dunn is the CEO of SI-BONE, Inc., where he has been leading the company since it was started in 2008. With a Bachelor's degree in Engineering and an MBA, he brings a solid educational background to his role. Dunn has a rich history in the medical device industry, having previously served as CEO at several tech companies before SI-BONE. Under his leadership, SI-BONE focuses on improving treatment for conditions involving the spine. Notably, in 2020, his total compensation reached $4.2 million, which included a large stock award indicating a strong belief in the company's future. Dunn has actively traded company stock throughout the years, with fluctuations in value showing his confidence and investment in SI-BONE. He continues to guide the company while also ensuring that the interests of shareholders align with business goals. Dunn's experience not only encompasses leadership but also navigating the complex world of health technology, making him a key figure in the company's ongoing success.

Quick Links

1. Rivals

2. Holdings

3. Insider Trading

4. Compensation History

5. Other SI-BONE, Inc. CEOs

S

Jeffrey W. Dunn

Ex-CEO of SI-BONE, Inc.

Education

Bachelor's degree in Engineering and an MBA

Field of Expertise

Business & Management

Sector of Economy

Healthcare

Born

January 1, 1964 - 61 years ago

CEO of SI-BONE, Inc. for

5 years 2 months (May 2015 - Jul 2020)

Previous Experience

Chief Executive Officer at SI-BONE, Inc. since May 2015, prior experience includes various leadership roles in medical device companies.

Rivals

Competitors/colleagues of Jeffrey W. Dunn

Holdings

See how much did Jeffrey W. Dunn make over time.

As CEO of SI-BONE, Jeffrey W. Dunn has seen significant changes in his stock holdings over the years. His investments peaked in early 2020 when insider trades reached $20.65 million in February, reflecting a strong belief in the company’s value....

As CEO of SI-BONE, Jeffrey W. Dunn has seen significant changes in his stock holdings over the years. His investments peaked in early 2020 when insider trades reached $20.65 million in February, reflecting a strong belief in the company’s value. Since then, his holdings have fluctuated, reaching new amounts monthly, but have not consistently stayed at the highs. For example, in late 2020, his holdings were around $10.45 million and gradually declined to around $2 million by early 2024. These figures demonstrate his active engagement in managing his investments related to SI-BONE and an evolving approach to capitalizing on market movements.

Mar 18, 2025

S

shares

SIBN @ $14.79

Total Stock Sold

$26.23M

SIBN

$26.23M

1,126,036 SIBN shares

What if they kept their stock?

If Jeffrey W. Dunn didn't sell their stock, today they would have:
Extra SIBN1,126,036 shares worth $15.34M.
This is -41.52% and $10.89M less than what they got when they sold the stock.

Charitable Transactions

SIBN

65,251 shares

SIBN

Recent Charitable Transactions

SIBN

65,251 shares

SIBN

Oct 21, 2021

Charity

Insider Trading

See recent insider trades of Jeffrey W. Dunn.

SIBN

$21.87K

SIBN at $13.84/share

Aug 16, 2024

Sale

SIBN

$4.91K

SIBN at $14.32/share

Aug 2, 2024

Sale

SIBN

8,791 shares

SIBN

Jun 26, 2024

Received

SIBN

$4.43K

SIBN at $12.99/share

Jun 10, 2024

Sale

SIBN

$23.92K

SIBN at $15.13/share

May 16, 2024

Sale

SIBN

$4.99K

SIBN at $14.54/share

May 2, 2024

Sale

SIBN

$87.17K

SIBN at $20.96/share

Feb 16, 2024

Sale

SIBN

$6.80K

SIBN at $20.30/share

Feb 2, 2024

Sale

SIBN

$140.92K

SIBN at $17.69/share

Nov 16, 2023

Sale

SIBN

$7.11K

SIBN at $17.52/share

Oct 21, 2021

Sale

Compensation History

See how much did Jeffrey W. Dunn make over time.

Jeffrey W. Dunn's compensation reflects his significant role at SI-BONE. In 2020, he earned a total of $4.2 million, including a salary of $555,000 and a bonus of $544,199 based on the company's performance. This bonus came from meeting corporate goals in revenue, cash flow, and clinical milestones. Notably, he received $3.1 million in stock awards, showing a strong link between his pay and the company’s future success. His compensation has varied over the years, with total compensation of $1.67 million in 2018 and about $1.16 million in 2019. His overall pay packages are designed to motivate and align his interests with those of SI-BONE's shareholders, emphasizing performance-based rewards that connect directly to the company's growth and success.

Year

2020

Total Compensation

$1.12M

Salary

$555.00K

Board Justification

The compensation programs are designed to attract, motivate, incentivize and retain employees at the executive level who contribute to long-term success, providing competitive compensation packages that reward achievement of business objectives and align interests with stockholders.

Bonus

$544.20K

Board Justification

Represents payments upon the achievement of 2020 corporate goals, as applicable, paid in January 2021.

Other

$22.03K

Board Justification

Includes medical and life insurance premiums paid by the company on behalf of the CEO.

Restricted Stock

$0.00(0 RSU)

Board Justification

No stock grants were vested in 2020 as the amounts reported are for stock awards granted, not vested.

Performance Metrics

The performance metrics included revenue growth, cash flow, expense management, profitability management, reimbursement progress, and clinical milestones.

Other SI-BONE, Inc. CEOs

Here are other CEOs of SI-BONE, Inc.

Laura A. Francis

CEO of SI-BONE, Inc.

July 2020 - Present